Chemoinformaics analysis of 4,5-Dihydroxy-2-hydroxymethyl-1,3,6,8-tetranitroanthraquinone
| Molecular Weight | 450.228 | nRot | 5 |
| Heavy Atom Molecular Weight | 444.18 | nRig | 1 |
| Exact Molecular Weight | 449.993 | nRing | 3 |
| Solubility: LogS | -5.22 | nHRing | 0 |
| Solubility: LogP | 5.231 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 12 |
| nHA | 13 | APOL | 43.8768 |
| nHD | 3 | BPOL | 12.4192 |
| QED | 0.404 |
| Synth | 1.639 |
| Natural Product Likeliness | 0.321 |
| NR-PPAR-gamma | 0.036 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.442 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.591 |
| MDCK | 0.000021 |
| BBB | 0.943 |
| PPB | 0.95571 |
| VDSS | 0.813 |
| FU | 0.0343453 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.465 |
| CYP2c19-inh | 0.668 |
| CYP2c19-sub | 0.357 |
| CYP2c9-inh | 0.45 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.102 |
| CYP3a4-inh | 0.344 |
| CYP3a4-sub | 0.107 |
| CL | 6.514 |
| T12 | 0.562 |
| hERG | 0.113 |
| Ames | 0.006 |
| ROA | 0.034 |
| SkinSen | 0.941 |
| Carcinogencity | 0.114 |
| EI | 0.976 |
| Respiratory | 0.84 |
| NR-Aromatase | 0.022 |
| Antiviral | No |
| Prediction | 0.518901 |